Cilostazol improves endothelial function in patients with ischemic stroke: A randomized controlled single-center study with flow-mediated dilation technique

J Neurol Sci. 2022 Aug 15:439:120318. doi: 10.1016/j.jns.2022.120318. Epub 2022 Jun 8.

Authors

Yuka Shirai¹, Sono Toi¹, Utako Adachi¹, Yukiko Tsutsumi¹, Kazuo Kitagawa²

Affiliations

¹ Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
² Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. Electronic address: kitagawa.kazuo@twmu.ac.jp.

PMID: 35749837
DOI: 10.1016/j.jns.2022.120318

No abstract available

Keywords: Cerebrovascular disease; Cilostazol; Flow-mediated dilation; Inflammatory markers; Vascular endothelial function.

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Brain Ischemia* / complications
Brain Ischemia* / diagnostic imaging
Brain Ischemia* / drug therapy
Cilostazol / therapeutic use
Dilatation
Humans
Ischemic Stroke*
Platelet Aggregation Inhibitors
Stroke* / diagnostic imaging
Stroke* / drug therapy
Tetrazoles / therapeutic use

Substances

Platelet Aggregation Inhibitors
Tetrazoles
Cilostazol